{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:24:05Z","timestamp":1791221045226,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":6734,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1111\/j.1600-6143.2004.00484.x","type":"journal-article","created":{"date-parts":[[2004,6,14]],"date-time":"2004-06-14T04:35:28Z","timestamp":1087187728000},"page":"1179-1183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Surrogate Markers for Long-Term Renal Allograft Survival"],"prefix":"10.1016","volume":"4","author":[{"given":"Sundaram","family":"Hariharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram","family":"Kasiske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Matas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Harmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Rabb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2004.00484.x_bib1","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJM198310063091401","article-title":"A randomized clinical trial of cyclosporine in cadaveric renal transplantation","volume":"309","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00007890-199508000-00003","article-title":"Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients","volume":"60","author":"Sollinger","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib3","first-page":"1321","article-title":"European Mycophenolate Mofetil Cooperative Study Group","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib4","first-page":"1029","article-title":"The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group","volume":"61","year":"1996","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib5","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00007890-199704150-00013","article-title":"A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation","volume":"63","author":"Pirsch","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0140-6736(00)02480-6","article-title":"Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomized multicenter study. The Rapamune US Study Group","volume":"356","author":"Kahan","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007890-200101270-00019","article-title":"A worldwide, Phase III, randomized, controlled, safety and efficacy study of a sirolimus\/cyclosporine regimen for the prevention of acute rejection in recipients of primary mismatched renal allografts","volume":"71","author":"Mcdonald","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM200003023420901","article-title":"Improved graft survival after renal transplantations in recipient in the United States, 1988 to 1996","volume":"342","author":"Hariharan","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1523-1755.2002.00424.x","article-title":"Post transplant renal function in the first year predicts long-term kidney transplant survival","volume":"62","author":"Hariharan","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib10","series-title":"Clinical Transplants","first-page":"257","article-title":"Single center analysis of 468 first cadaveric kidney allograft with uniform ATG-CsA sequential therapy","author":"Giral","year":"1996"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib11","series-title":"Clinical Transplants","first-page":"1","article-title":"Scientific Renal Transplant Registry","author":"Cecka","year":"1998"},{"issue":"A46","key":"10.1111\/j.1600-6143.2004.00484.x_bib12","first-page":"149","article-title":"Development of a surrogate marker of long-term kidney allograft outcome based on serum creatinine and calculated creatinine clearance at 6 months post-transplant","volume":"2","author":"Tesi","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib13","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1053\/ajkd.2001.28605","article-title":"Comparing methods for monitoring serum creatinine to predict late renal allograft survival","volume":"38","author":"Kasiske","year":"2001","journal-title":"Am J Kid Dis"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib14","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1097\/01.ASN.0000070621.06264.86","article-title":"The change in allograft function among long-term kidney transplant recipients","volume":"14","author":"Gill","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib15","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/clinchem\/46.8.1206","article-title":"Changes in plasma cystatin C after renal transplantation and acute rejection in adults","volume":"46","author":"Le Bricon","year":"2000","journal-title":"Clin Chem"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0009-8981(01)00522-8","article-title":"Serum cystatin C in renal transplant patients","volume":"310","author":"Paskalev","year":"2001","journal-title":"Clin Chim Acta"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib17","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/00007890-200210270-00002","article-title":"Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine","volume":"74","author":"Flechner","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib18","first-page":"1560","article-title":"Poor predictive value of serum creatinine for allograft loss","volume":"3","author":"Kaplan","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib19","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.V9112129","article-title":"Beneficial effect of treatment of early subclinical rejection: a randomized study","volume":"9","author":"Rush","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00007890-200102270-00006","article-title":"Effect of histological damage on long-term kidney transplant outcome","volume":"71","author":"Nankivel","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00007890-199907270-00013","article-title":"Computerized histomorphometric assessment of protocol renal transplant biopsy specimen for surrogate markers of chronic rejection","volume":"68","author":"Nicholson","year":"1999","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib22","first-page":"1195","article-title":"Histological chronic allograft damage index accurately predicts chronic renal allograft rejection","volume":"58","author":"Isoniemi","year":"1994","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00007890-200102270-00017","article-title":"Prevalence of donor-specific anti-HLA antibodies during episodes of renal allograft rejection","volume":"71","author":"Supon","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib24","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM200103293441301","article-title":"Noninvasive diagnosis of renal allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine","volume":"344","author":"Li","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib25","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1097\/01.TP.0000054679.91112.6F","article-title":"When renal allografts turn DARC","volume":"75","author":"Segerer","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib26","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1034\/j.1600-6143.2003.00132.x","article-title":"Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients","volume":"3","author":"Hricik","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib27","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/00007890-200210150-00003","article-title":"Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury","volume":"74","author":"Hoffmann","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa035588","article-title":"Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling","volume":"349","author":"Sarwal","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib29","first-page":"217","article-title":"Association of chronic kidney graft failure with recipient blood pressure. Collaborative transplant study","volume":"53","author":"Opelz","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib30","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1399-0012.1998.tb01087.x","article-title":"Post kidney transplant quality of life prediction models","volume":"12","author":"Hathaway","year":"1998","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1399-0012.1998.tb01097.x","article-title":"Long-term quality of life after kidney and simultaneous pancreas-kidney transplantation","volume":"12","author":"Matas","year":"1998","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib32","first-page":"156","article-title":"High serum apolipoprotein AIV levels in renal transplant recipients","volume":"55","author":"Massy","year":"2001","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib33","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1034\/j.1600-6143.2003.00176.x","article-title":"Evolution of endpoints for renal transplant outcome","volume":"3","author":"Hariharan","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib34","series-title":"Clinical Trials: a Methodologic Perspective","author":"Piantadosi","year":"1997"},{"key":"10.1111\/j.1600-6143.2004.00484.x_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-6143.2004.00386.x","article-title":"Biomarkers and surrogate endpoints in renal transplantation: present status and considerations for clinical trial design","volume":"4","author":"Lachenbruch","year":"2004","journal-title":"Am J Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2004.00484.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522075712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522075712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2004.00484.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:31:03Z","timestamp":1761625863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522075712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S1600613522075712"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2004.00484.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surrogate Markers for Long-Term Renal Allograft Survival","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2004.00484.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}